David Shaw’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

David Shaw’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-40,000	Closed	-$1.88M	–	4438
2019 Q4	$1.88M	Buy	+40,000	New	+$1.77M	﹤0.01%	2527

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

David Shaw's RARX Position: Q2 2020 in Review

David Shaw sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 25,580 shares — an estimated $1.23M sold.

David Shaw first reported a position in RARX in Q4 2016 and held it in 11 quarters. The position peaked at $12.5M in Q2 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

David Shaw reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
David Shaw sold 25,580 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $1.23M.
David Shaw first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2016 and held it in 11 quarters.
David Shaw's Ra Pharmaceuticals, Inc. Common Stock position peaked at $12.5M in Q2 2019.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on D.E. Shaw & Co's 13F filing for Q2 2020, filed 14 Aug 2020.